Clinical Trial Update: Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating duloxetine for the prevention of post-ERCP pancreatitis in patients with biliary disease; the study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Diseases
• Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis

Drugs mentioned

• Duloxetine (DULOXETINE)

Snippet

Sponsor: Tanta University | Conditions: Biliary Disease | Phase 3 | Status: RECRUITING